Emerging Infectious Diseases (Apr 2012)

Human Parvovirus 4 Infection, Cameroon

  • Myriam Lavoie,
  • Colin P. Sharp,
  • Jacques Pépin,
  • Christopher Pennington,
  • Yacouba Foupouapouognigni,
  • Oliver G. Pybus,
  • Richard Njouom,
  • Peter Simmonds

DOI
https://doi.org/10.3201/eid1804.110628
Journal volume & issue
Vol. 18, no. 4
pp. 680 – 683

Abstract

Read online

In a post hoc analysis of samples collected in 2009, we determined seroprevalence of parvovirus 4 (PARV4) among elderly Cameroonians. PARV4 seropositivity was associated with receipt of intravenous antimalarial drugs, intramuscular streptomycin, or an intramuscular contraceptive, but not hepatitis C virus seropositivity. Findings suggest parenteral acquisition of some PARV4 infections.

Keywords